← Leaderboards
John F Alcorn
University Of Pittsburgh At Pittsburgh
$9,508,312
Attributed
$13,496,737
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,496,737 · 9
By mechanism
R01$10,910,698 · 4
U01$1,297,795 · 1
R21$848,973 · 2
P30$346,499 · 1
F32$92,772 · 1
Top collaborators
- Jishnu Das6 shared
- Harinder Singh6 shared
- Richard K Zimmerman4 shared
- Jason Edward Shoemaker2 shared
- Sarah L. Gaffen1 shared
- Mandy J Mcgeachy1 shared
- Lianghui Zhang1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Jishnu Das$5,608,209
- Harinder Singh$15,916,174
- David W Volk$3,146,037
- Bruce Robert Pitt$8,182,501
- Imad Al Ghouleh$1,947,775
Others in their field
Top investigators on “Influenza”
- Richard Webby · St. Jude Children'S Research Hospital$247,579,041
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$102,941,847
- Adolfo Garcia-Sastre · Jackson Laboratory$94,049,184
- Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai$72,751,763
- John Beigel · Leidos Biomedical Research, Inc.$72,410,171
- Ted Ross · University Of Georgia$71,962,304
Research focus
InfluenzaCytokinePathway InteractionsCellsMolecularImmunityImmune ResponseLungInfectionPredispositionIn VitroLaboratoriesPneumoniaT-LymphocyteMouse ModelMorbidity - Disease RateEpithelial CellsMediatingStaphylococcus AureusCessation Of LifeMortalityResponseLung InjuryBacterial Infections
Grant awards (32)
Uncovering latent factors underlying weak and robust responses to influenza vaccine in healthy and obese older adults$762,973
R01 · FY2025 · AI · contact PI
Pathogenic mechanisms of chronic lung sequelae following respiratory viral infection$754,729
R01 · FY2025 · HL
B and Tfh cell dynamics underlying durable antibody responses to flu vaccine in children$683,050
U01 · FY2025 · AI
The Role of Staphylococcus aureus SasD in Lung$528,628
R01 · FY2025 · HL · contact PI
Uncovering latent factors underlying weak and robust responses to influenza vaccine in healthy and obese older adults$780,295
R01 · FY2024 · AI · contact PI
B and Tfh cell dynamics underlying durable antibody responses to flu vaccine in children$614,745
U01 · FY2024 · AI
The Role of Staphylococcus aureus SasD in Lung$518,055
R01 · FY2024 · HL · contact PI
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia$496,186
R01 · FY2024 · HL · contact PI
Uncovering latent factors underlying weak and robust responses to influenza vaccine in healthy and obese older adults$775,988
R01 · FY2023 · AI · contact PI
The Role of Staphylococcus aureus SasD in Lung$571,647
R01 · FY2023 · HL · contact PI
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia$506,312
R01 · FY2023 · HL · contact PI
Uncovering latent factors underlying weak and robust responses to influenza vaccine in healthy and obese older adults$775,914
R01 · FY2022 · AI · contact PI
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia$540,727
R01 · FY2022 · HL · contact PI
Viral impact on autoimmune T cells$236,718
R21 · FY2022 · AI
Mathematical Modeling of Influenza Severity in Outbred Mice$189,830
R21 · FY2022 · AI · contact PI
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia$506,378
R01 · FY2021 · HL · contact PI
Mathematical Modeling of Influenza Severity in Outbred Mice$228,212
R21 · FY2021 · AI · contact PI
Viral impact on autoimmune T cells$194,213
R21 · FY2021 · AI
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia$391,250
R01 · FY2020 · HL · contact PI
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia$391,250
R01 · FY2019 · HL · contact PI
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia$390,626
R01 · FY2018 · HL · contact PI
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia$387,813
R01 · FY2017 · HL · contact PI
Alcorn Pilot$115,500
P30 · FY2017 · DK · contact PI
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia$372,570
R01 · FY2016 · HL · contact PI
Alcorn Pilot$115,500
P30 · FY2016 · DK · contact PI
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia$366,981
R01 · FY2015 · HL · contact PI
Alcorn Pilot$115,499
P30 · FY2015 · DK · contact PI
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia$365,119
R01 · FY2014 · HL · contact PI
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia$354,687
R01 · FY2013 · HL · contact PI
Influenza A Inhibits TH17 Host Defense Against Bacterial Pneumonia$372,570
R01 · FY2012 · HL · contact PI
The Role of JNK in Allergen-Induced Airway Remodeling$48,796
F32 · FY2006 · HL · contact PI
The Role of JNK in Allergen-Induced Airway Remodeling$43,976
F32 · FY2005 · HL